MAC1 - Overview: Myelopathy, Autoimmune/Paraneoplastic Evaluation, Spinal Fluid
Evaluating patients with suspected autoimmune myelopathy, myelitis, and paraneoplastic myelopathy using spinal fluid specimens
EPS2 - Overview: Epilepsy, Autoimmune/Paraneoplastic Evaluation, Serum
Investigating new onset cryptogenic epilepsy with incomplete seizure control and duration of less than 2 years, using serum specimens Investigating new onset cryptogenic epilepsy plus 1 or more of the following accompaniments: -Psychiatric...
AIAES - Overview: Axonal Neuropathy, Autoimmune/Paraneoplastic Evaluation, Serum
Evaluation of patients who present with a subacute neurological disorder of undetermined etiology, especially those with known risk factors for cancer Directing a focused search for cancer Investigating neurological symptoms that appear...
BIOTS - Overview: Biotinidase, Serum
Preferred test for the diagnosis of biotinidase deficiency Follow-up testing for certain organic acidurias
AGNTC - Overview: Anti-Glial/Neuronal Nuclear Antibody-Type 1 (AGNA-1) Titer, Spinal Fluid
Reporting an end titer result from cerebrospinal fluid (CSF) specimens Serological evaluation using CSF specimens from patients who present with a subacute neurological disorder of undetermined etiology, especially those with risk factors...
CMVLR - Overview: Cytomegalovirus (CMV) Molecular Detection, PCR, Lower Respiratory
Rapid qualitative detection of cytomegalovirus (CMV) DNA in lower respiratory specimens This test is not intended for the monitoring of CMV disease progression or response to therapy.
THEV0 - Overview: Thalassemia Summary Interpretation, Blood
Incorporating and summarizing subsequent molecular results into an overall interpretation for the THEV1 / Thalassemia and Hemoglobinopathy Evaluation, Blood and Serum
Simultaneous detection and differentiation of SARS-CoV-2 (cause of COVID-19), influenza A virus, and influenza B virus in upper or lower respiratory tract specimens from individuals with flu-like illnesses
HIAA - Overview: 5-Hydroxyindoleacetic Acid, 24 Hour, Urine
Biochemical diagnosis and monitoring of intestinal carcinoid syndrome using 24-hour urine specimens
DYS2 - Overview: Dysautonomia, Autoimmune/Paraneoplastic Evaluation, Serum
Investigating idiopathic dysautonomic symptoms Directing a focused search for cancer in patients with idiopathic dysautonomia Investigating autonomic symptoms that appear in the course or wake of cancer therapy and are not explainable by...
Register today for Classical Hematology 2023 - Insights
Taking place on October 3–4, 2023, in Rochester, Minnesota, the Classical Hematology 2023 conference focuses on addressing the evaluation of frequently encountered blood count abnormalities. The conference...
Top 5 Mayo Clinic Laboratories advancements in 2024 - Insights
Five of the most significant advancements from Mayo Clinic Laboratories in 2024 to enhance diagnostics and patient care globally....
Visit Mayo Clinic Laboratories at Medlab Middle East 2023 - Insights
announce our participation in Medlab Middle East 2023, a medical conference and exhibition taking place in Dubai, United Arab Emirates, Feb. 6–9, 2023....
Visit Mayo Clinic Laboratories at Medlab Middle East 2024 - Insights
announce our participation in Medlab Middle East 2024, a medical conference and exhibition taking place in Dubai, United Arab Emirates, Feb. 5–8, 2024....
Managing Compliance in Preparation for 2025 Updates - Insights
With updates expected to federal compliance guidance for laboratories in 2025, now is a great time to revisit existing guidelines and plans....